DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slipped 2.18% to $20.62 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.22% to 21,449.29 and Dow Jones Industrial Average falling 0.77% to 45,282.47.
The stock's fall snapped a four-day winning streak.
Catalyst Pharmaceuticals Inc. closed 22.42% short of its 52-week high of $26.58, which the company achieved on June 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.49% to $178.41, Pfizer Inc. $(PFE)$ fell 2.86% to $25.14, and Abbott Laboratories $(ABT)$ fell 0.54% to $131.87.
Trading volume (1.8 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
August 25, 2025 17:23 ET (21:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.